PROK
PROK
NASDAQ · Biotechnology

Prokidney Corp

$1.80
+0.03 (+1.69%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 10 67%
Hold 4 27%
Sell 1 7%
Price Target
Analyst Price Target +1,001.1% upside
Low Target $13.43
Average Target $19.82
High Target $25.07
Current Price $1.80
Current
$1.80
Target
$19.82
$13.43 $19.82 avg $25.07
Scenario Analysis
Bear Case
$13.43
646.1%
Low target
Base Case
$19.82
+1,001.1%
Avg target
Bull Case
$25.07
+1,292.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$7.13
-74.8% from high
52-Week Low
$0.54
+233.3% from low
Target vs 52W High
$19.82
+178.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -36.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.5%